Boulder Care is a telehealth addiction-care provider for people seeking treatment for opioid or alcohol use disorder. On May 22, 2024, the Portland-based company announced a $35 million Series C led by Advance Venture Partners (AVP). Boulder said the funding would help it meet demand and expand access, particularly through health-plan partnerships and value-based care.
What is Boulder Care?
Boulder Care is an online clinic, not a consumer product company. Its model brings together clinician visits and medication management with peer recovery support, care coordination, social-service navigation, and an app-based point of access. The company also discusses treatment for kratom and 7-OH use on its website. Boulder Care’s treatment website describes the services and encourages prospective patients to check eligibility.
Boulder says its approach is based on harm reduction and patient goals: it does not require abstinence or discharge patients for missing visits or returning to substance use. These are descriptions of the company’s care model, not a guarantee of any individual outcome.
Why did Boulder Care raise $35 million?
In its May 22, 2024 Series C announcement, Boulder said the capital would support its response to rising demand and help expand access to addiction treatment. The company highlighted partnerships with health plans and value-based care as central to that expansion.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
AVP led the round. Stripes and existing investors First Round Capital, Qiming Venture Partners, and Laerdal Million Lives Fund also participated. Founder and CEO Stephanie Strong said the company was advancing addiction medicine through research, education, and advocacy; that statement reflects Boulder’s stated priorities, not independent validation of its results.
What does Boulder Care treat, and what care does it offer?
Opioid use disorder
Boulder describes clinician-directed medication management for opioid use disorder, including buprenorphine, sometimes known by the brand name Suboxone. A clinician determines whether a medication is appropriate; it is not a product for patients to select or use without medical guidance.
Alcohol use disorder
The company also offers care for alcohol use disorder and names naltrexone as one possible medication option. Treatment decisions belong with a qualified clinician and depend on the person’s circumstances.
Peer and practical support
Alongside clinical care, Boulder describes peer recovery support, care coordination, and help navigating social services. Its stated model is intended to address practical and recovery needs as well as medication and clinician visits.
Rank #3
How does online addiction treatment work?
Boulder’s enrollment page outlines a basic sequence: create an account in the app, meet with a provider in a private video visit, and pick up any prescribed medication at a pharmacy. The specific care plan and prescription, if any, are determined by the clinician.
- Set up an account: Start through Boulder’s app-based enrollment process.
- Meet a provider: Attend a private video appointment for an evaluation and discussion of care options.
- Follow the care plan: If a prescription is appropriate, the company says patients pick it up at a pharmacy; peer support and coordination may also be part of care.
Boulder’s contact page identifies primary-care providers, social workers, case managers, and parole officers among potential referral sources.
Does Boulder Care take Medicaid?
Boulder says it works with Medicaid and major insurance plans, but actual access depends on location, plan, and eligibility. Check the company’s current eligibility information directly before relying on coverage or availability; accepted plans and service locations may change.
In a May 22, 2024 GeekWire interview, Strong said 80% of Boulder patients were covered by Medicaid. That is an executive-reported figure from 2024, not a current audited payer breakdown.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteWhat does the $35 million round say about Boulder’s business?
The financing story is about scaling a care provider through institutional relationships, rather than selling a standalone app or medication. Health plans, Medicaid managed-care organizations, employers, and clinical or community referral networks are relevant channels for this kind of model. Boulder’s funding announcement specifically emphasized health plans and value-based care; its 2024 interview also highlighted its focus on Medicaid.
The company said it had served more than 12,000 patients nationwide by the time of the 2024 Series C announcement. This is an announcement-era company figure, not a verified current patient count. For comparison, Boulder announced a $36 million Series B in 2022; that earlier round is historical context, not a current funding update. Boulder’s June 10, 2022 release records that financing.
Boulder’s current website displays figures of 93% meeting goals to reduce unwanted use, 74% rating recovery progress good to excellent, and an NPS of 86. The page does not display a publication date or methodology with those figures, so they should be read as company website claims rather than independently verified outcome evidence.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
